Ligand Pharmaceuticals (LGND) Current Deferred Tax Assets: 2011-2015
Historic Current Deferred Tax Assets for Ligand Pharmaceuticals (LGND) over the last 3 years, with Sep 2015 value amounting to $7.5 million.
- Ligand Pharmaceuticals' Current Deferred Tax Assets was N/A to $7.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $7.5 million, marking a year-over-year change of. This contributed to the annual value of $8,000 for FY2012, which is 96.62% down from last year.
- According to the latest figures from Q3 2015, Ligand Pharmaceuticals' Current Deferred Tax Assets is $7.5 million, which was up 93,862.50% from $8,000 recorded in Q3 2013.
- In the past 5 years, Ligand Pharmaceuticals' Current Deferred Tax Assets registered a high of $7.5 million during Q3 2015, and its lowest value of $8,000 during Q4 2012.
- For the 2-year period, Ligand Pharmaceuticals' Current Deferred Tax Assets averaged around $1.9 million, with its median value being $8,000 (2013).
- Data for Ligand Pharmaceuticals' Current Deferred Tax Assets shows a maximum YoY tumbled of 96.62% (in 2012) over the last 5 years.
- Ligand Pharmaceuticals' Current Deferred Tax Assets (Quarterly) stood at $237,000 in 2011, then slumped by 96.62% to $8,000 in 2012, then tumbled by 96.62% to $8,000 in 2013, then reached $7.5 million in 2015.
- Its Current Deferred Tax Assets was $7.5 million in Q3 2015, compared to $8,000 in Q3 2013 and $8,000 in Q2 2013.